Showing results (761-770 of 1,286) with videos related to

Sort By:
Pageof 129
Journal of Cardiovascular Pharmacology and Therapeutics|February 23, 2000
Effects of Sotalol on the Circadian Rhythmicity of Heart Rate and QT Intervals With a Noninvasive Index of Reverse-Use DependencySharma, Sarma, Singh
Journal of Cardiovascular Pharmacology and Therapeutics|February 23, 2000
Increased Intramural Retention After Local Delivery of Molecules with Increased Binding Properties: Implications for Regional Delivery of Pharmacologic AgentsWilensky, Mehdi, Sowinski, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|February 23, 2000
Persistence of Atrial Fibrillation After Its Induction-Importance of the Duration and Dispersion of Atrial Refractoriness and Electrical RemodelingRahme, Cotter, Leistad, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|February 23, 2000
Recurrent Torsades de Pointes After Sotalol Therapy for Symptomatic Paroxysmal Atrial Fibrillation in a Patient with End-Stage Renal DiseaseRizza, Valderrabano, Singh
Journal of Cardiovascular Pharmacology and Therapeutics|February 23, 2000
Protamine Reversal of Heparin After Cardiopulmonary Bypass Increases Lung Resistance, Not ElastanceGilbert, Barnas, Miller, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|February 23, 2000
Domoic Acid Attenuates the Adenosine-5'-Triphosphate-Induced Increase inNijjar, Pierce, Nijjar, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|February 23, 2000
Superoxide Anion Generation, Superoxide Dismutase Activity, and Nitric Oxide Release in Human Internal Mammary Artery and Saphenous Vein SegmentsSchmalfuss, Chen, Bott, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|July 14, 2001
Fenoldopam infusion associated with preserving renal function after aortic cross-clamping for aneurysm repairT B Gilbert, J U Hasnain, W R Flinn, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 30, 2021
Evaluation of TReatment With Angiotensin Converting Enzyme Inhibitors and the Risk of Lung Cancer: ERACER-An Observational Cohort StudyJeffrey L Anderson, Kirk U Knowlton, J Brent Muhlestein, et al.
Pageof 129